gamma-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists.
Cherney
Robert J
RJ
Research and Development, Bristol-Myers Squibb Company, Princeton, NJ 08543-4000, USA. robert.cherney@bms.com
Mo
Ruowei
R
Meyer
Dayton T
DT
Voss
Matthew E
ME
Yang
Michael G
MG
Santella
Joseph B
JB
Duncia
John V
JV
Lo
Yvonne C
YC
Yang
Gengjie
G
Miller
Persymphonie B
PB
Scherle
Peggy A
PA
Zhao
Qihong
Q
Mandlekar
Sandhya
S
Cvijic
Mary Ellen
ME
Barrish
Joel C
JC
Decicco
Carl P
CP
Carter
Percy H
PH